by Hwa Jin Cho, Silver Heinsar, In Seok Jeong,
Kiran Shekar, Gianluigi Li Bassi, Jae Seung Jung, Jacky Y. Suen and John F.
Fraser
Critical Care 24, Article number: 301 (2020)
The spread of coronavirus disease 2019 (COVID-19) continues
to grow exponentially in most countries, posing an unprecedented burden on the
healthcare sector and the world economy. Previous respiratory virus outbreaks,
such as severe acute respiratory syndrome (SARS), pandemic H1N1 and Middle East
respiratory syndrome (MERS), have provided significant insights into
preparation and provision of intensive care support including extracorporeal
membrane oxygenation (ECMO). Many patients have already been supported with
ECMO during the current COVID-19 pandemic, and it is likely that many more may
receive ECMO support, although, at this point, the role of ECMO in
COVID-19-related cardiopulmonary failure is unclear. Here, we review the
experience with the use of ECMO in the past respiratory virus outbreaks and
discuss potential role for ECMO in COVID-19.
No comments:
Post a Comment